Related references
Note: Only part of the references are listed.Normal responses to specific NOD1-activating peptidoglycan agonists in the presence of the NOD2 frameshift and other mutations in Crohn's disease
DA van Heel et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2006)
Attenuation of MPTP-induced neurotoxicity and locomotor dysfunction in Nucling-deficient mice via suppression of the apoptosome pathway
XC Teng et al.
JOURNAL OF NEUROCHEMISTRY (2006)
Tumour necrosis factor-α as a tumour promoter
P Szlosarek et al.
EUROPEAN JOURNAL OF CANCER (2006)
Fas-associated factor-1 inhibits nuclear factor-κB (NF-κB) activity by interfering with nuclear translocation of the RelA (p65) subunit of NF-κB
MY Park et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Nucling recruits Apaf-1/pro-caspase-9 complex for the induction of stress-induced apoptosis
T Sakai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Nucling mediates apoptosis by inhibiting expression of galectin-3 through interference with nuclear factor κB signalling
L Liu et al.
BIOCHEMICAL JOURNAL (2004)
To be, or not to be:: NF-κB is the answer -: role of Rel/NF-κB in the regulation of apoptosis
J Kucharczak et al.
ONCOGENE (2003)
Identification of a novel, embryonal carcinoma cell-associated molecule, Nucling, that is up-regulated during cardiac muscle differentiation
T Sakai et al.
JOURNAL OF BIOCHEMISTRY (2003)
Identification of a novel A20-binding inhibitor of nuclear factor-κB activation termed ABIN-2
S Van Huffel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
The pro- or anti-apoptotic function of NF-κB is determined by the nature of the apoptotic stimulus
B Kaltschmidt et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2000)
Share Paper
